Meiling Sun

614 total citations
28 papers, 499 citations indexed

About

Meiling Sun is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Meiling Sun has authored 28 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Meiling Sun's work include Antimicrobial Peptides and Activities (3 papers), Cancer therapeutics and mechanisms (3 papers) and Peptidase Inhibition and Analysis (3 papers). Meiling Sun is often cited by papers focused on Antimicrobial Peptides and Activities (3 papers), Cancer therapeutics and mechanisms (3 papers) and Peptidase Inhibition and Analysis (3 papers). Meiling Sun collaborates with scholars based in China, United States and Japan. Meiling Sun's co-authors include Lijuan Cao, Zheng‐Hong Qin, Richard D. Ye, Caihong Zhou, Zhipeng Zhou, Yu‐Qiang Ding, Jin‐Hua Gu, Rong Han, Yuanyuan Qin and Mei Li and has published in prestigious journals such as Nucleic Acids Research, Journal of Neuroscience and The Journal of Immunology.

In The Last Decade

Meiling Sun

25 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meiling Sun China 14 290 97 62 57 54 28 499
Xue Sun China 16 325 1.1× 60 0.6× 41 0.7× 42 0.7× 48 0.9× 40 675
Hua Qin China 18 361 1.2× 45 0.5× 53 0.9× 30 0.5× 44 0.8× 33 789
Fei Qian China 12 216 0.7× 73 0.8× 51 0.8× 31 0.5× 91 1.7× 26 474
Juanjuan Han China 15 379 1.3× 119 1.2× 48 0.8× 37 0.6× 72 1.3× 40 653
Junling Yang China 14 205 0.7× 68 0.7× 29 0.5× 63 1.1× 43 0.8× 24 465
Minghua Li China 13 285 1.0× 157 1.6× 30 0.5× 44 0.8× 49 0.9× 22 483
Joseph R. Inigo United States 10 360 1.2× 107 1.1× 76 1.2× 22 0.4× 44 0.8× 13 553
Duolu Li China 14 299 1.0× 168 1.7× 47 0.8× 24 0.4× 48 0.9× 32 522
Qianliang Wang China 12 252 0.9× 89 0.9× 38 0.6× 16 0.3× 69 1.3× 30 471

Countries citing papers authored by Meiling Sun

Since Specialization
Citations

This map shows the geographic impact of Meiling Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiling Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiling Sun more than expected).

Fields of papers citing papers by Meiling Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meiling Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiling Sun. The network helps show where Meiling Sun may publish in the future.

Co-authorship network of co-authors of Meiling Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Meiling Sun. A scholar is included among the top collaborators of Meiling Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meiling Sun. Meiling Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Meiling, et al.. (2025). Combining Immunotherapy with Anlotinib in Extensive-Stage Small Cell Lung Cancer: A Multicenter Analysis of Efficacy and Safety. Technology in Cancer Research & Treatment. 24. 2244071136–2244071136.
4.
Li, Chonghui, et al.. (2023). An intellectual disability-related MED23 mutation dysregulates gene expression by altering chromatin conformation and enhancer activities. Nucleic Acids Research. 51(5). 2137–2150. 8 indexed citations
5.
Chen, Yiru, et al.. (2023). Development and Validation of Prognostic Nomograms Based on Lymph Node Ratio for Young Patients with Gastric Cancer: A SEER-Based Study. Technology in Cancer Research & Treatment. 22. 2223899811–2223899811.
6.
Horimoto, Katsuhisa, Tadamasa Sasaki, Kazuhiko Fukui, et al.. (2023). Phosphorylated protein chip combined with artificial intelligence tools for precise drug screening. Journal of Biomedical Research. 38(3). 195–195. 1 indexed citations
7.
Zhou, Jiajing, et al.. (2023). Curcumin Induces Ferroptosis in A549 CD133+ Cells through the GSH-GPX4 and FSP1-CoQ10-NAPH Pathways. Discovery Medicine. 35(176). 251–251. 30 indexed citations
8.
Xu, Angao, Yanfei Gao, Yue Xie, et al.. (2021). Graphene oxide exacerbates dextran sodium sulfate-induced colitis via ROS/AMPK/p53 signaling to mediate apoptosis. Journal of Nanobiotechnology. 19(1). 85–85. 36 indexed citations
9.
Huang, Xin, Rong Chen, Meiling Sun, et al.. (2020). Frame-shifted proteins of a given gene retain the same function. Nucleic Acids Research. 48(8). 4396–4404. 12 indexed citations
10.
Zhang, Xiao, et al.. (2017). FoxO3a plays a key role in the protective effects of pomegranate peel extract against amikacin-induced ototoxicity. International Journal of Molecular Medicine. 40(1). 175–181. 14 indexed citations
11.
Wu, Jiayuan, Lijuan Cao, Meiling Sun, et al.. (2015). Protease Omi cleaving Hax-1 protein contributes to OGD/R-induced mitochondrial damage in neuroblastoma N2a cells and cerebral injury in MCAO mice. Acta Pharmacologica Sinica. 36(9). 1043–1052. 32 indexed citations
12.
Li, Mei, Meiling Sun, Lijuan Cao, et al.. (2014). A TIGAR-Regulated Metabolic Pathway Is Critical for Protection of Brain Ischemia. Journal of Neuroscience. 34(22). 7458–7471. 93 indexed citations
13.
Li, Lili, Rui Lin, Hua He, et al.. (2013). Interaction of amidated single-walled carbon nanotubes with protein by multiple spectroscopic methods. Journal of Luminescence. 145. 125–131. 15 indexed citations
14.
Yu, Jingping, et al.. (2011). Enhancement of Radiosensitivity and the Potential Mechanism on Human Esophageal Carcinoma Cells by Tetrandrine. Cancer Biotherapy and Radiopharmaceuticals. 26(4). 437–442. 18 indexed citations
15.
Yu, Jingping, et al.. (2011). The Enhancement of Radiosensitivity in Human Esophageal Carcinoma Cells by Thalidomide and Its Potential Mechanism. Cancer Biotherapy and Radiopharmaceuticals. 26(2). 219–227. 13 indexed citations
16.
Zhou, Caihong, Meiling Sun, Xin Wang, et al.. (2007). Discovery of Trp-Nle-Tyr-Met as a novel agonist for human formyl peptide receptor-like 1. Biochemical Pharmacology. 74(2). 317–326. 12 indexed citations
17.
Zhou, Caihong, Song Zhang, Masakatsu Nanamori, et al.. (2007). Pharmacological Characterization of a Novel Nonpeptide Antagonist for Formyl Peptide Receptor-Like 1. Molecular Pharmacology. 72(4). 976–983. 39 indexed citations
18.
Yan, Pangke, Masakatsu Nanamori, Meiling Sun, et al.. (2006). The Immunosuppressant Cyclosporin A Antagonizes Human Formyl Peptide Receptor through Inhibition of Cognate Ligand Binding. The Journal of Immunology. 177(10). 7050–7058. 35 indexed citations
19.
Tian, Xiao Yu, Jing Li, Xin Xie, et al.. (2005). Stereospecific Induction of Nuclear Factor-κB Activation by Isochamaejasmin. Molecular Pharmacology. 68(6). 1534–1542. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026